DEBATE: DCB for In-Stent Restenosis: Does the Current Data Support Broad Adoption? Yes! The Data is Solid and DCB Should be the Treatment of Choice!
Presenter:
New at TCTMD? Register today!
Enter the email you used to register to reset your password.